GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.30 $3.29 Friday, 19th Apr 2024 ABUS stock ended at $2.72. This is 0.366% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 6.04% from a day low at $2.65 to a day high of $2.81.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
2023-10-19 $1.81 $1.81 $1.71 $1.75 552 598
2023-10-18 $1.86 $1.86 $1.77 $1.78 490 220
2023-10-17 $1.90 $1.92 $1.86 $1.89 476 965
2023-10-16 $1.85 $1.93 $1.85 $1.89 413 684
2023-10-13 $1.83 $1.89 $1.81 $1.86 469 347
2023-10-12 $1.87 $1.87 $1.81 $1.84 679 377
2023-10-11 $1.95 $1.96 $1.87 $1.87 353 055
2023-10-10 $1.85 $1.94 $1.84 $1.94 605 489
2023-10-09 $1.90 $1.90 $1.73 $1.86 868 770
2023-10-06 $1.88 $1.94 $1.87 $1.94 737 522
2023-10-05 $1.89 $1.91 $1.87 $1.90 556 940
2023-10-04 $1.89 $1.90 $1.84 $1.89 786 411
2023-10-03 $1.92 $1.93 $1.87 $1.88 441 860
2023-10-02 $2.01 $2.02 $1.91 $1.92 763 829
2023-09-29 $2.00 $2.05 $1.99 $2.03 1 160 395
2023-09-28 $2.02 $2.04 $1.99 $2.00 752 726
2023-09-27 $1.95 $2.04 $1.95 $2.01 676 757
2023-09-26 $1.92 $2.00 $1.91 $1.94 526 600
2023-09-25 $1.93 $1.93 $1.87 $1.90 730 003
2023-09-22 $1.97 $1.97 $1.88 $1.93 1 127 366
2023-09-20 $1.98 $2.03 $1.98 $2.00 445 670
2023-09-19 $1.99 $2.00 $1.96 $1.98 459 255
2023-09-18 $2.02 $2.04 $1.98 $1.99 543 078
2023-09-15 $2.05 $2.07 $2.00 $2.04 1 221 218
2023-09-14 $2.03 $2.08 $2.03 $2.05 408 659
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT